Japan: Reviving the Pharmaceutical Industry, Reality Check: Lessons from Overseas. (1/2)
It’s not just money that is lacking. Successful development of medical therapeutics in Japan, including vaccines, takes transparency and ethical policies.
We would like to share the commentary by Dr Aldric Hama, who works in the biomedical sector and lives in Shizuoka Prefecture. He received his PhD in anatomy and cell biology from the University of Illinois, Chicago and ever since has worked with various pharmaceutical and biotechnology companies, which originally appeared in Japan Forward, August 13, 2022.
